Rachael Dangarembizi, Christoph D. Rummel, Joachim Roth, Kennedy H. Erlwanger, Michael T. Madziva, & Lois M. Harden. (2019). Pyrogenic and neuroinflammatory properties of zymosan and its potential as an alternative to live yeast in antipyretic drug testing. Canadian Science Publishing.
Chicago Style (17th ed.) CitationRachael Dangarembizi, Christoph D. Rummel, Joachim Roth, Kennedy H. Erlwanger, Michael T. Madziva, and Lois M. Harden. Pyrogenic and Neuroinflammatory Properties of Zymosan and Its Potential as an Alternative to Live Yeast in Antipyretic Drug Testing. Canadian Science Publishing, 2019.
MLA (9th ed.) CitationRachael Dangarembizi, et al. Pyrogenic and Neuroinflammatory Properties of Zymosan and Its Potential as an Alternative to Live Yeast in Antipyretic Drug Testing. Canadian Science Publishing, 2019.